Actively Recruiting
PumaRx Registry Trial
Led by RenovoRx · Updated on 2026-03-30
1000
Participants Needed
3
Research Sites
213 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.
CONDITIONS
Official Title
PumaRx Registry Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients diagnosed with solid tumor cancers
- At least 18 years old at the time of the first intra-arterial procedure
- Willing to provide informed consent and HIPAA release for use of medical records
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Baptist Health South Florida
Coral Gables, Florida, United States, 33143
Actively Recruiting
2
University of Pennsylvania Medical Center
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
3
The University of Vermont Medical Center
Burlington, Vermont, United States, 05401
Actively Recruiting
Research Team
L
Leesa M Gentry
CONTACT
N
Nicolette G Keller
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here